| abstract |
FIELD: medicine. n SUBSTANCE: invention describes crystals of 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine (prasugrel) hydrobromate, comprisions of crystals and pharmaceutical compositions containing them for preventing and treating the diseases associated with thrombus or embolism in an animal. n EFFECT: there are prepared new crystals of prasugrel hydrobromate which possess improved stability and solubility, and can find application in medicine. n 13 cl, 7 dwg, 3 tbl, 11 ex |